Most T cell subsets depend on IL-7 for survival. IL-7 binds to IL-7Rα and γc, initiating the signaling cascade. Deletion of IL-7Ra in humans has, for some time, been known to cause severe combined immunodeficiency. More recently, polymorphisms in IL-7R have been shown be a risk factor for a number of diseases that are autoimmune or involve excess immune and inflammatory responses including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, primary biliary cirrhosis, inflammatory bowel disease, atopic dermatitis, inhalation allergy, sarcoidosis and graft-versus host disease. The polymorphism that affects risk to most of these immunopathologies is T244I at the border of the extracellular domain and the transmembrane region. The same region has recently been shown to harbor gain-of-function mutations in acute lymphoblastic leukemia. These studies have suggested new therapies that target the IL-7 pathway. © 2012.

The human IL-7 receptor gene: Deletions, polymorphisms and mutations / R.I. Mazzucchelli, A. Riva, S.K. Durum. - In: SEMINARS IN IMMUNOLOGY. - ISSN 1044-5323. - 24:3(2012 Jun), pp. 225-230. [10.1016/j.smim.2012.02.007]

The human IL-7 receptor gene: Deletions, polymorphisms and mutations

R.I. Mazzucchelli
Primo
;
A. Riva;
2012

Abstract

Most T cell subsets depend on IL-7 for survival. IL-7 binds to IL-7Rα and γc, initiating the signaling cascade. Deletion of IL-7Ra in humans has, for some time, been known to cause severe combined immunodeficiency. More recently, polymorphisms in IL-7R have been shown be a risk factor for a number of diseases that are autoimmune or involve excess immune and inflammatory responses including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, primary biliary cirrhosis, inflammatory bowel disease, atopic dermatitis, inhalation allergy, sarcoidosis and graft-versus host disease. The polymorphism that affects risk to most of these immunopathologies is T244I at the border of the extracellular domain and the transmembrane region. The same region has recently been shown to harbor gain-of-function mutations in acute lymphoblastic leukemia. These studies have suggested new therapies that target the IL-7 pathway. © 2012.
IL-7; IL-7R; T244I
Settore MEDS-10/B - Malattie infettive
giu-2012
16-mar-2012
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S104453231200022X-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 291.27 kB
Formato Adobe PDF
291.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
nihms360290.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Licenza: Non specificato
Dimensione 400.77 kB
Formato Adobe PDF
400.77 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1179726
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 57
  • OpenAlex 76
social impact